2.0
Apr 27, 2023
Current employee
Recommend
CEO approval
Business Outlook
Pros
Preeminent gene editing company with smart, innovative, high-performing people. Diverse therapeutic areas/modalities in distinct franchises. Each franchise is like a small biotech so opportunity for a long-term career development by moving across different franchises.
Cons
There is blatant favoritism. The top level inner circle is a handful of young management consultants. There is zero interest in valuing experienced drug developers ideas and perspectives. McKinsey training is valued above all else. The lack of experience is going to be detrimental to the future success of the company .